PER 1.41% 7.0¢ percheron therapeutics limited

per-chart, page-1078

  1. 1,703 Posts.
    lightbulb Created with Sketch. 605
    My reference to being unknown related solely to the local investor community which would be the driver for imminent FOMO you refer to. I have no doubt about the knowledge of the scientific community (“big boys” ) which you mention. I’m pretty happy with my homework & corporate acumen by the way. The science alone will not drive the SP to where it should be. It’ll also come down to the quality of any deal, the timing of that deal(s), engagement with the DMD community & or the progress of any competitors to market.
    Last edited by Upthefog: Today, 16:11
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.